Sep 07, 2023 / 03:20PM GMT
Peter Verdult - Citigroup Inc., Research Division - MD
Okay. So good morning, everyone. It's good to -- we finally got Pfizer out the building. Delighted to be here from the pharma team, delighted to be moderating and hosting Jazz Pharma. We have Renee, Rob and Abizer, who are the -- I get it right, CFO, Head of R&D and Oncology, respectively. Rene is going to make some opening remarks. You've heard me say this at times time. I'm here to moderate monopolize. So if any of you want to ask a question, stick your hand out, there's a microphone in the room, and we'll get your questions answered. But team Jazz, thank you very much for coming. Rene, over to you for some opening remarks.
Renee D. Gala - Jazz Pharmaceuticals plc - Executive VP & CFO
Great. Thank you, and thanks for the invitation. So just a few reminders. We will be making forward-looking statements today please consult our website and the SEC filings for more information about our business, including risk factors. Should we make reference to financial guidance. We're not updating or reiterating
Jazz Pharmaceuticals PLC at Citi BioPharma Conference Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers